Securing Gene Synthesis Act
Latest action · Jul 21, 2023 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJul 18, 2023
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Securing Gene Synthesis Act
This bill requires the Department of Health and Human Services to issue regulations to prevent the misuse of de novo gene synthesis products (i.e., manufactured gene products), including screening protocols for providers of these products. Federal agencies and entities that receive federal funds may only purchase such products from providers that comply with the screening protocols.
Cosponsors 2
Members who signed on, in the order they did. Signatures ran from Sep 12, 2023 to Feb 15, 2024.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-CA | Ted Lieu | Sep 12, 2023 | |
| D-CA | Julia Brownley | Feb 15, 2024 |
Actions 3
Everything that happened, newest first.
- Jul 21, 2023Referred to the Subcommittee on Health.
- Jul 18, 2023Introduced in House
- Jul 18, 2023Referred to the House Committee on Energy and Commerce.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 2400 | Securing Gene Synthesis Act | Identical bill | Jul 19, 2023 |
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Jul 18, 2023Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.